Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Glaxosmithkline (GSK) Share News

LONDON BRIEFING: DCC sells unit; South32 warns of Mozal impairment

14th Jul 2025 07:54

(Alliance News) - DCC announced a deal to sell a part of its technology arm for GBP100 million, GSK is pursuing US approval for expanded use of its RSV jab, while South32 warned of an impairment at an aluminium smelter in Mozambique. Read More

LONDON MARKET CLOSE: FTSE 100 eases from record levels amid soft GDP

11th Jul 2025 16:57

(Alliance News) - London's FTSE 100 closed a winning week on the back foot after soft economic growth figures and threats of further tariffs from the US. Read More

LONDON BROKER RATINGS: Jet2 raised to 'buy'; Investec cuts Pagegroup

11th Jul 2025 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON MARKET OPEN: Europe rises despite new US tariff mayhem

9th Jul 2025 08:56

(Alliance News) - Stock prices in Europe opened in the green on Wednesday, shaking off a more stern tone from US President Donald Trump on trade policy, though the threat of sector tariffs on copper and pharmaceuticals hit miners and drug makers. Read More

LONDON MARKET CLOSE: Pound climbs, bond yields ease as PM backs Reeves

3rd Jul 2025 16:58

(Alliance News) - The FTSE 100 and sterling rallied, while the bond market calmed on Thursday as Keir Starmer supported his chancellor, reassuring markets that a change at the Treasury wasn't on the cards. Read More

UK dividends calendar - next 7 days

3rd Jul 2025 16:44

LONDON BROKER RATINGS: Babcock International price targets raised

30th Jun 2025 09:38

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

GSK drug to treat itch caused by liver disease accepted for EU review

23rd Jun 2025 09:55

(Alliance News) - GSK PLC on Monday said linerixibat has been accepted for review by the European Medicines Agency for the treatment of intense itching caused by a rare autoimmune liver disease. Read More

LONDON MARKET CLOSE: FTSE 100 underperforms Europe despite Iran talks

20th Jun 2025 17:04

(Alliance News) - London's FTSE 100 faded into the close on Friday, ending lower, as weak retail sales data and falls in heavyweight oil and drug stocks offset hopes for progress in the Israel-Iran conflict. Read More

Japan accepts GSK application for expanded use of RSV vaccine Arexvy

20th Jun 2025 08:27

(Alliance News) - GSK PLC on Friday announced that Japan has accepted a regulatory application to expand the use of its respiratory syncytial virus [RSV] vaccine Arexvy. Read More

LONDON MARKET CLOSE: FTSE 100 nudges up ahead of Fed after in line CPI

18th Jun 2025 16:53

(Alliance News) - London's FTSE 100 posted modest gains on Wednesday amid ongoing Middle East tensions, as investors weighed broadly in line UK inflation data ahead of rate calls on either side of the pond. Read More

DIRECTOR DEALINGS: New B&M CEO Tjeerd Jegen buys GBP500,000 in shares

17th Jun 2025 12:36

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced in the past several days and not separately reported by Alliance News: Read More

LONDON MARKET CLOSE: Stocks up on hopes of thaw to Middle East tension

16th Jun 2025 17:05

(Alliance News) - The FTSE 100 ended higher on Monday, just shy of a record closing high, on reports Iran is willing to resume nuclear talks with the US. Read More

LONDON MARKET CLOSE: Stocks slide, oil jumps after Israel strikes Iran

13th Jun 2025 17:06

(Alliance News) - The oil price soared and stocks slumped on Friday after Israel launched dozens of air strikes against Iran, ramping up tensions in the Middle East. Read More

GSK's RSV drug Arexvy accepted for regulatory review in Europe

13th Jun 2025 08:14

(Alliance News) - GSK PLC on Friday said its respiratory syncytial virus vaccine, Arexvy, has been accepted for regulatory review by the European Medicines Agency to expand its use in adults 18 years and older. Read More

CORRECT: PHP hits back after Assura backs KKR offer

13th Jun 2025 07:58

(Correcting currency of bid for Adriatic Metals.) Read More

LONDON BRIEFING: PHP hits back after Assura backs KKR offer

13th Jun 2025 07:45

(Alliance News) - The FTSE 100 is set to open lower on Friday, though its oil majors could save it from a deeper decline, as Brent prices jumped following an Israeli strike on Iran's nuclear facilities. Read More

DIRECTOR DEALINGS: Cerillion CEO seeks to sell GBP20 million in shares

12th Jun 2025 13:28

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and Thursday and not separately reported by Alliance News: Read More

IN BRIEF: GSK launches second tranche of GBP2 billion share buyback

4th Jun 2025 08:07

GSK PLC - London-based pharmaceutical company - Starts on Wednesday the second tranche of its previously announced GBP2.0 billion share buyback programme. The new tranche, worth up to GBP450.0 million, follows the completion of a first tranche of GBP700.0 million on Tuesday. Merrill Lynch International will run the second tranche, after Citigroup Global Markets Ltd ran the first. It will be completed by September 19. Shares bought will be held in treasury. Read More

LONDON BRIEFING: UK steel industry welcomes latest tariff decision

4th Jun 2025 07:50

(Alliance News) - Stocks were called higher in the UK on Wednesday, as industry spokespeople cautiously welcome Donald Trump's decision to keep tariffs at 25% on British steel and aluminium for now. Read More

FTSE 100 Latest

Value9,100.77

Change-63.54